928CVR018
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
CVR-DOGWOOD THERAPEUTICS INC
πΊπΈ NYSE/NASDAQ
π Overview
π Performance
π΅ Cost
π Esg
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
N/A
Annual Growth
5 years average annual growth
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
π Performance
Price History*
N/A
1M
All Time
Graph
Table
Performance graph isn't available yet for this share
* US price history does not take into account stock splits
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in 928CVR018
1
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in 928CVR018
N/A
928CVR018 investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
100%
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
100%
35 - 90
π Legal gender of investors
Female
Male
100%
Pearlers who invest in 928CVR018 also invest in...
π Performance (5Yr p.a)
17.19%
π Share price
$524.95 USD
π HIGH PRICE GROWTH